Supervised and home-based physical exercise in patients newly diagnosed with multiple myeloma—a randomized controlled feasibility study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2055-5784
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Supervised and home-based physical exercise in patients newly diagnosed with multiple myeloma—a randomized controlled feasibility study ; volume:5 ; number:1 ; day:12 ; month:11 ; year:2019 ; pages:1-11 ; date:12.2019
Pilot and feasibility studies ; 5, Heft 1 (12.11.2019), 1-11, 12.2019
- Urheber
-
Larsen, Rikke Faebo
Jarden, Mary
Minet, Lisbeth Rosenbek
Frølund, Ulf Christian
Abildgaard, Niels
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40814-019-0518-2
- URN
-
urn:nbn:de:101:1-2020030920422393163312
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Larsen, Rikke Faebo
- Jarden, Mary
- Minet, Lisbeth Rosenbek
- Frølund, Ulf Christian
- Abildgaard, Niels
- SpringerLink (Online service)
Ähnliche Objekte (12)
Muscle and fat composition in patients with newly diagnosed multiple myeloma
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma
The Cost Impact of Lenalidomide for Newly Diagnosed Multiple Myeloma in the EU5
Short overview on the current standard of treatment in newly diagnosed multiple myeloma
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
Muscle and fat composition in patients with newly diagnosed multiple myeloma
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma
The Cost Impact of Lenalidomide for Newly Diagnosed Multiple Myeloma in the EU5
Short overview on the current standard of treatment in newly diagnosed multiple myeloma
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
Muscle and fat composition in patients with newly diagnosed multiple myeloma
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma
The Cost Impact of Lenalidomide for Newly Diagnosed Multiple Myeloma in the EU5
Short overview on the current standard of treatment in newly diagnosed multiple myeloma
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis